Scientific Information

Registration, welcome coffee and exhibit visit

Opening

Paolo Manzoni, Louis Bont

Opening lectures: The year in review

Paolo Manzoni, Louis Bont

The human infant nose organoid (HNO) platform to study virus-host biology and for the evaluation of monoclonal antibody and other therapeutics: a specific model for assessing infants’ response to respiratory syncytial virus and SARS-CoV-2.  translating into pragmatical skills

Pedro A Piedra, USA

Symposium on the “Premature birth and the association with recurrent wheeze and asthma: the impact of early life RSV prevention”.

Chairman: Louis Bont
-Renato Stein - Mechanisms and background
- Eugenio Baraldi – The current evidence
- Adnan Custovic – How to prevent?

Break exhibit visit

Composite, long-term sequelae of RSV-LRTI and potential impact of new interventions

Heather Zar, SAF

Molecular epidemiology of respirator viruses after the Covid pandemic

Thomas C. Williams, UK (virtual)

The RSV vaccines pipeline

Louis Bont, NED

Day closing remarks

Paolo Manzoni, Louis Bont

Opening

Paolo Manzoni, Louis Bont

The RSV burden in LMIC

Nathalie Mazur, NED

Mini symposium “Maternal vaccination for RSV – clinically measurable benefits”

1. Latest updates and published evidence – Luis Bont
2. The Ob-Gyn perspective - Fernando Althabe, ARG
3. The Neonatologist perspective - Paolo Manzoni, ITA
4. Future scenarios and pending gaps - Matthew Snape, UK

Coffee Break- Exhibit walk

Astra Zeneca sponsored lecture : “RSV infection- a look back to the last 25 years”

O. Ramilo, USA
Chairman: Gianluca Lista, ITA

Overview of future vaccines for respiratory viruses in infancy

Marta Nunes

Closing remarks

Paolo Manzoni, Louis Bont

Exhibhit visit, ICCN registration, poster walk

ICCN Opening

Paolo Manzoni

Opening lecture: Game-changing RCTs in Neonatology: what did happen in the last year?

Neena Modi, UK

Neonatal hypoglycemia, a never ending story

Nestor Vain, ARG

New protocols on diaphragmatic hernia

Ruben Bromiker, ISR

Platform presentation session: new science and ongoing research

• NEONATAL MORBIDITIES AND FEEDING TOLERANCE OUTCOMES IN VERY PRE-TERM INFANTS, BEFORE AND AFTER INTRODUCTION OF PROBIOTICS SUPPLE-MENTATION
  Stefan Johansson, SWE
• Caffeine use after NICU discharge: evidence from a prospective RCT
  Timm Vedder, USA
• Increasing the use of OMM in the NiCU: An evidence-based initiative to in-crease use of own mothers milk in a NiCU: the impact of COVID-19
  Rosalina Barroso, POR
• Pharmacoeconomic model for prevention of respiratory viral morbidity in Italy
  Barry Rodgers Gray, UK
• Neonatal outcomes after complicated labour
  Alessandro Messina, IT
• National survey of ophtalmia neonatorum
  Vito Mondì, IT

Human milk bank: from generalized to individualized nutrition

Manuel Sanchez Luna, SPA

Closing remarks

Paolo Manzoni

Anti seizures drugs and role of electric and/or clinical seizures in newborns: all you need to know

Renato S Procianoy, BRA

Respiratory control issues, oxygenation instability and their impact on neonatal outcomes

Eduardo Bancalari, USA

Prevention and Treatment of necrotizing enterocolitis in preterm infants What is on the horizon?

Sanjay Patole, AUS

Noise reduction and language development in the NICU – an unsolveable dilemma?

Angelika Berger, AUT

Break, exhibhit visit, poster walk

The role of lung ultrasound in NICU - an update

Daniele De Luca, FRA

What is the role of IGF-1 in future BPD prevention? Facts and fiction

Boris Kramer, NED

The All-Four position at delivery and its possible impact on neonatal outcomes

Bianca Masturzo, ITA

Lunch break, exhibit visit, poster walk

Neonatal Neurology Symposium

Under the auspices and endorsement of the NBS- Newborn Brain Society
Chair: Mohamed El-Dib, USA (virtual only)

• Neuroprotection in the term infant- current status and future directions Nikki Robertson, UK
• Multimodality remote brain monitoring and outcomes Gabriel Variane, BRA
• Mild Neonatal Encephalopathy- Will we ever agree ? Brian Walsh, IRL

The Future of Neonatology

collaborative plans to develop and disseminate the ENRICH Statement for Embedding Necessary Research Into Culture and Health
William Tarnow Mordi, AUS

To close or not to close: new data on the management of PDA

Tim Hundscheid , NED

Closing remarks

Paolo Manzoni